RCELAVITA Medical, Inc.

Nasdaq avitamedical.com


$ 8.34 $ 0.09 (1.09 %)    

Monday, 13-May-2024 15:59:58 EDT
QQQ $ 442.84 $ 1.02 (0.23 %)
DIA $ 394.52 $ -0.72 (-0.18 %)
SPY $ 520.61 $ 0.07 (0.01 %)
TLT $ 90.36 $ 0.23 (0.26 %)
GLD $ 216.28 $ -2.45 (-1.12 %)
$ 8.35
$ 8.54
$ 0.00 x 0
$ 0.00 x 0
$ 8.33 - $ 8.70
$ 7.97 - $ 21.70
230,697
na
10.77M
$ 2.91
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-13-2024 03-31-2024 10-Q
2 02-22-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-10-2023 06-30-2023 10-Q
5 05-11-2023 03-31-2023 10-Q
6 02-23-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-11-2022 06-30-2022 10-Q
9 05-12-2022 03-31-2022 10-Q
10 02-28-2022 12-31-2021 10-K
11 11-08-2021 09-30-2021 10-Q
12 08-26-2021 06-30-2021 10-K
13 05-13-2021 03-31-2021 10-Q
14 02-16-2021 12-31-2020 10-Q
15 11-10-2020 09-30-2020 10-Q
16 08-27-2020 06-30-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 avita-medical-sees-q2-commercial-revenue-143m-153m-fy24-commercial-revenue-expected-to-be-in-the-lower-end-of-previous-guidance-of-785m-845m

Financial GuidanceCommercial revenue for the second quarter 2024 is expected to be in the range of $14.3 to $15.3 millionCommer...

 avita-medical-q1-eps-073-misses-045-estimate-sales-1110m-beat-1105m-estimate

AVITA Medical (NASDAQ:RCEL) reported quarterly losses of $(0.73) per share which missed the analyst consensus estimate of $(0.4...

 nasdaq-jumps-250-points-crude-oil-down-1

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite surging more than 250 points on Thursday. The D...

 why-fastenal-shares-are-trading-lower-by-around-7-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter f...

 dow-dips-100-points-carmax-earnings-miss-views

U.S. stocks traded mixed midway through trading, with the Dow Jones index falling around 100 points on Thursday.

 carmax-reports-downbeat-earnings-joins-lovesac-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session

U.S. stock futures were lower this morning, with the Dow futures falling over 150 points on Thursday.

 btig-downgrades-avita-medical-to-neutral

BTIG analyst Ryan Zimmerman downgrades AVITA Medical (NASDAQ:RCEL) from Buy to Neutral.

 why-rallybio-shares-are-trading-higher-by-around-78-here-are-20-stocks-moving-premarket

Shares of Rallybio Corporation (NASDAQ: RLYB) rose sharply in today’s pre-market trading after the company announced a collabo...

 avita-medical-eyes-lower-end-of-previously-provided-2024-revenue-guidance-of-785m-845m-est-80093m

AVITA Medical plans to report its financial results for the first quarter 2024 after the close of the U.S. financial markets on...

 avita-medical-cuts-q1-commercial-revenue-forecast-citing-slower-than-expected-conversion-rate-of-new-accounts-for-expanded-label-of-full-thickness-skin-defects

For the quarter ended March 31, 2024, AVITA Medical now expects commercial revenue to be in the range of $11.0 million to $11.3...

 cantor-fitzgerald-maintains-overweight-on-avita-medical-raises-price-target-to-25

Cantor Fitzgerald analyst Ross Osborn maintains AVITA Medical (NASDAQ:RCEL) with a Overweight and raises the price target fr...

 ardelyx-posts-q4-loss-joins-mercadolibre-booking-holdings-and-other-big-stocks-moving-lower-in-fridays-pre-market-session

U.S. stock futures were lower this morning, with the Dow futures trading lower by around 25 points on Friday.

 avita-sees-q1-2024-revenue-148m-156m-vs-15766m-estimate

Financial GuidanceCommercial revenue for the first quarter 2024 is expected to be in the range of $14.8 to $15.6 million, refle...

 avita-medical-q4-2023-gaap-eps-028-beats-038-estimate-sales-1420m-miss-1450m-estimate

AVITA Medical (NASDAQ:RCEL) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate of $(0.38)...

 earnings-scheduled-for-february-22-2024

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on reve...

 earnings-preview-avita-medical
Earnings Preview: AVITA Medical
02/21/2024 18:02:01

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION